F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Chronic hepatitis C

Page 1 of 2 ( 86 items )
<<
1
2
>>

1	Non-invasive prediction of significant hepatic fibrosis in individuals with chronic hepatitis C infection using fibrosis risk score and machine learning models 3/26/2026 9:22:59 AM \| Browse: 0 \| Download: 0
2	Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals 10/27/2025 10:57:49 AM \| Browse: 192 \| Download: 293
3	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 138 \| Download: 342
4	Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease 8/27/2025 9:21:09 AM \| Browse: 184 \| Download: 414
5	Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs 6/26/2025 7:27:55 AM \| Browse: 145 \| Download: 598
6	Transient elastography and diffusion-weighted magnetic resonance imaging for assessment of liver fibrosis in children with chronic hepatitis C 8/29/2024 7:51:41 AM \| Browse: 146 \| Download: 798
7	Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma 3/27/2024 1:28:19 PM \| Browse: 198 \| Download: 693
8	Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019) 3/11/2024 2:44:49 PM \| Browse: 318 \| Download: 1080
9	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 348 \| Download: 1429
10	Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways 11/24/2023 6:10:12 AM \| Browse: 311 \| Download: 1343
11	Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways 11/24/2023 6:10:11 AM \| Browse: 483 \| Download: 1137
12	Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report 10/25/2023 8:49:11 AM \| Browse: 356 \| Download: 1153
13	Sarcopenia in chronic viral hepatitis: From concept to clinical relevance 5/24/2023 9:31:05 AM \| Browse: 381 \| Download: 1072
14	Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C 2/10/2023 9:15:29 AM \| Browse: 437 \| Download: 1091
15	Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients 6/9/2022 7:17:55 AM \| Browse: 712 \| Download: 2358
16	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 708 \| Download: 1788
17	Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study 11/10/2021 7:13:09 AM \| Browse: 936 \| Download: 1636
18	Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis 5/14/2021 10:27:31 AM \| Browse: 813 \| Download: 1907
19	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 633 \| Download: 1914
20	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 698 \| Download: 1649
21	Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients 2/25/2021 3:45:30 PM \| Browse: 1038 \| Download: 2421
22	Management of hepatitis C in children and adolescents during COVID-19 pandemic 8/25/2020 9:16:00 AM \| Browse: 910 \| Download: 1901
23	Liver-related effects of chronic hepatitis C antiviral treatment 6/14/2020 1:45:26 PM \| Browse: 1173 \| Download: 2206
24	Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus 4/23/2020 10:34:55 AM \| Browse: 771 \| Download: 2402
25	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1376 \| Download: 2186
26	Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy 8/26/2019 2:56:47 AM \| Browse: 1020 \| Download: 3033
27	High prevalence of occult hepatitis C infection in predialysis patients 1/27/2019 7:04:05 AM \| Browse: 1046 \| Download: 2299
28	Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus 10/12/2018 5:32:21 AM \| Browse: 916 \| Download: 1670
29	Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection 3/26/2018 8:48:04 AM \| Browse: 1471 \| Download: 3328
30	Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis 1/26/2018 8:09:36 AM \| Browse: 1373 \| Download: 2293
31	Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1 12/27/2017 10:31:19 AM \| Browse: 1334 \| Download: 2702
32	Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment 7/7/2017 11:41:16 AM \| Browse: 1234 \| Download: 2780
33	Interferon related pericarditis: Review 6/26/2017 12:49:43 AM \| Browse: 1314 \| Download: 1865
34	Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting 6/14/2017 9:25:57 AM \| Browse: 1306 \| Download: 2777
35	Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C 6/7/2017 7:22:42 AM \| Browse: 2115 \| Download: 4202
36	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1616 \| Download: 2791
37	Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b 4/6/2017 6:30:00 PM \| Browse: 1434 \| Download: 2388
38	Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C 2/27/2017 8:50:00 AM \| Browse: 1372 \| Download: 2290
39	Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data 2/17/2017 8:32:00 AM \| Browse: 1381 \| Download: 2200
40	Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C 11/26/2016 6:56:00 PM \| Browse: 1395 \| Download: 3158
41	Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature 11/6/2016 3:43:00 PM \| Browse: 1118 \| Download: 1894
42	Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 10/14/2016 1:37:00 PM \| Browse: 1402 \| Download: 2033
43	Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C 9/30/2016 5:59:00 PM \| Browse: 1387 \| Download: 2983
44	Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication 9/4/2016 2:49:00 PM \| Browse: 1583 \| Download: 2585
45	Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles 7/29/2016 8:32:00 PM \| Browse: 1346 \| Download: 2445
46	Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? 4/19/2016 9:45:00 AM \| Browse: 1429 \| Download: 3390
47	Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1 3/23/2016 4:26:00 PM \| Browse: 1558 \| Download: 2813
48	Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage 1/20/2016 5:04:00 PM \| Browse: 1456 \| Download: 1985
49	Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver 12/10/2015 10:35:00 AM \| Browse: 1298 \| Download: 1878
50	Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching 12/4/2015 3:24:00 PM \| Browse: 1321 \| Download: 3089

Page 1 of 2 ( 86 items )
<<
1
2
>>

1	Non-invasive prediction of significant hepatic fibrosis in individuals with chronic hepatitis C infection using fibrosis risk score and machine learning models 3/26/2026 9:22:59 AM \| Browse: 0 \| Download: 0
2	Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals 10/27/2025 10:57:49 AM \| Browse: 192 \| Download: 293
3	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 138 \| Download: 342
4	Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease 8/27/2025 9:21:09 AM \| Browse: 184 \| Download: 414
5	Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs 6/26/2025 7:27:55 AM \| Browse: 145 \| Download: 598
6	Transient elastography and diffusion-weighted magnetic resonance imaging for assessment of liver fibrosis in children with chronic hepatitis C 8/29/2024 7:51:41 AM \| Browse: 146 \| Download: 798
7	Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma 3/27/2024 1:28:19 PM \| Browse: 198 \| Download: 693
8	Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019) 3/11/2024 2:44:49 PM \| Browse: 318 \| Download: 1080
9	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 348 \| Download: 1429
10	Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways 11/24/2023 6:10:12 AM \| Browse: 311 \| Download: 1343
11	Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways 11/24/2023 6:10:11 AM \| Browse: 483 \| Download: 1137
12	Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report 10/25/2023 8:49:11 AM \| Browse: 356 \| Download: 1153
13	Sarcopenia in chronic viral hepatitis: From concept to clinical relevance 5/24/2023 9:31:05 AM \| Browse: 381 \| Download: 1072
14	Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C 2/10/2023 9:15:29 AM \| Browse: 437 \| Download: 1091
15	Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients 6/9/2022 7:17:55 AM \| Browse: 712 \| Download: 2358
16	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 708 \| Download: 1788
17	Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study 11/10/2021 7:13:09 AM \| Browse: 936 \| Download: 1636
18	Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis 5/14/2021 10:27:31 AM \| Browse: 813 \| Download: 1907
19	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 633 \| Download: 1914
20	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 698 \| Download: 1649
21	Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients 2/25/2021 3:45:30 PM \| Browse: 1038 \| Download: 2421
22	Management of hepatitis C in children and adolescents during COVID-19 pandemic 8/25/2020 9:16:00 AM \| Browse: 910 \| Download: 1901
23	Liver-related effects of chronic hepatitis C antiviral treatment 6/14/2020 1:45:26 PM \| Browse: 1173 \| Download: 2206
24	Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus 4/23/2020 10:34:55 AM \| Browse: 771 \| Download: 2402
25	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1376 \| Download: 2186
26	Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy 8/26/2019 2:56:47 AM \| Browse: 1020 \| Download: 3033
27	High prevalence of occult hepatitis C infection in predialysis patients 1/27/2019 7:04:05 AM \| Browse: 1046 \| Download: 2299
28	Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus 10/12/2018 5:32:21 AM \| Browse: 916 \| Download: 1670
29	Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection 3/26/2018 8:48:04 AM \| Browse: 1471 \| Download: 3328
30	Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis 1/26/2018 8:09:36 AM \| Browse: 1373 \| Download: 2293
31	Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1 12/27/2017 10:31:19 AM \| Browse: 1334 \| Download: 2702
32	Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment 7/7/2017 11:41:16 AM \| Browse: 1234 \| Download: 2780
33	Interferon related pericarditis: Review 6/26/2017 12:49:43 AM \| Browse: 1314 \| Download: 1865
34	Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting 6/14/2017 9:25:57 AM \| Browse: 1306 \| Download: 2777
35	Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C 6/7/2017 7:22:42 AM \| Browse: 2115 \| Download: 4202
36	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1616 \| Download: 2791
37	Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b 4/6/2017 6:30:00 PM \| Browse: 1434 \| Download: 2388
38	Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C 2/27/2017 8:50:00 AM \| Browse: 1372 \| Download: 2290
39	Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data 2/17/2017 8:32:00 AM \| Browse: 1381 \| Download: 2200
40	Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C 11/26/2016 6:56:00 PM \| Browse: 1395 \| Download: 3158
41	Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature 11/6/2016 3:43:00 PM \| Browse: 1118 \| Download: 1894
42	Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 10/14/2016 1:37:00 PM \| Browse: 1402 \| Download: 2033
43	Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C 9/30/2016 5:59:00 PM \| Browse: 1387 \| Download: 2983
44	Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication 9/4/2016 2:49:00 PM \| Browse: 1583 \| Download: 2585
45	Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles 7/29/2016 8:32:00 PM \| Browse: 1346 \| Download: 2445
46	Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? 4/19/2016 9:45:00 AM \| Browse: 1429 \| Download: 3390
47	Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1 3/23/2016 4:26:00 PM \| Browse: 1558 \| Download: 2813
48	Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage 1/20/2016 5:04:00 PM \| Browse: 1456 \| Download: 1985
49	Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver 12/10/2015 10:35:00 AM \| Browse: 1298 \| Download: 1878
50	Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching 12/4/2015 3:24:00 PM \| Browse: 1321 \| Download: 3089